Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer
In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX
Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks
NCI’s Goal To Increase Minority Participation In Trials, Sondik Says
UT Southwestern, M.D. Anderson Form Cancer Center In Dallas
NCI Scientists Immunize A Healthy BMT Donor Against Myeloma
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









